255 results on '"Sakamaki H"'
Search Results
2. Tobacco smoking is associated with infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation
3. Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy
4. Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT
5. Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT
6. Clinical impact of pre-transplant diastolic function on outcome after allogeneic hematopoietic SCT
7. THE ANALYSIS OF HEMATOGONES (HGS) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT): PH-P386
8. Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT
9. Risk factors and organ involvement of chronic GVHD in Japan
10. Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation: This article has been corrected since Advance Online Publication and an erratum is also printed in this issue.
11. Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
12. Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation: This article has been corrected since Advance Online Publication and a Corrigendum is also printed in this issue
13. Salvage allogeneic hematopoietic SCT for primary graft failure in children
14. Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia
15. The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis
16. New-onset microalbuminuria following allogeneic myeloablative SCT is a sign of near-term decrease in renal function
17. Clinical outcomes of allogeneic haematopoietic stem cell transplantation with intravenous busulfan-based reducedintensity conditioning for acute myeloid leukaemia: a nationwide retrospective study from the adult AML working group of JSHCT: O380
18. Invasive fungal infections after allogeneic haematopoietic stem cell transplantation in Japan: O364
19. Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry
20. Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT
21. The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT
22. Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR
23. Anti-host isohemagglutinin production is associated with a higher risk of acute GVHD in ABO-incompatible transplantation
24. Second allogeneic hematopoietic SCT for relapsed ALL in children
25. Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT
26. Secondary solid tumors after allogeneic hematopoietic SCT in Japan
27. Fatal intracranial hemorrhage following administration of recombinant thrombomodulin in a patient after cord blood transplantation
28. Third allogeneic stem cell transplantation for the treatment of acute leukaemia: P1215
29. Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphoblastic leukaemia in first complete remission: comparisons between related and unrelated, and myeloablative and reduced-intensity conditioning transplantation: P915
30. Long-term effect of kidney shielding during total body irradiation: a single-centre experience: P690
31. Air-leak syndrome following allo-SCT in adult patients: report from the Kanto Study Group for Cell Therapy in Japan
32. A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT
33. Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study
34. Cystatin C level as a marker of renal function in haematopoietic stem cell transplantation: R1245
35. Clinical characteristics of early-onset acute graft-versushost disease after allogeneic haematopoietic stem cell transplantation: R1228
36. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT
37. Treatment of adult AML with t(6;11)(q27;q23) by allogeneic hematopoietic SCT in the first CR
38. Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese survey
39. Disease-specific analyses of unrelated cord blood transplant compared with unrelated bone marrow transplant in adult patients with acute leukaemia
40. Clinical features of allogeneic hematopoietic stem cell transplantation-associated organizing pneumonia
41. Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease
42. Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years
43. Recovery of Vα24+ NKT cells after hematopoietic stem cell transplantation
44. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan
45. Allogeneic myeloablative transplantation for patients aged 50 years and over
46. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation
47. Clinical features and treatment of hematopoietic stem cell transplantation-associated gastric antral vascular ectasia
48. Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
49. Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT
50. Erratum: Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.